Ultra-low-molecular-weight heparin (ULMWH) semuloparin for prevention of venous thromboembolism (VTE) in cancer patients receiving chemotherapy: consistent beneficial effect across cancer stage and location subgroups

Pas encore traduit Pas encore traduit
Catégorie Primary study
JournalEuropean Journal of Cancer
Year 2011
Loading references information
Cet article n'a pas de résumé
Epistemonikos ID: 800a11891cd747af08b76c16d8aa6237b26cab2a
First added on: Mar 17, 2016